Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real-world study
表皮生长因子受体靶向抗体尼妥珠单抗联合放化疗可改善局部晚期头颈部鳞状细胞癌患者的生存期：一项倾向评分匹配的真实世界研究
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.608
Zhang, Peng; Zhang, Xinxin; Lang, Jinyi; Wu, Shaoxiong; Sun, Yan; Wang, Peiguo; Qiu, Sufang; Huang, Xiaodong; Ren, Guoxin; Liu, Kun; Du, Xiaojing; Xiao, Shaowen; Wang, Zhongqiu; Weng, Youliang; Zhang, Ye; Zhou, Hang; Tu, Wenyong; Zhang, Chenping; Yi, Junlin
